Joseph R. Berger, MD, shares significant insights regarding neuromyelitis optica spectrum disorders (NMOSD) presented at the recent ECTRIMS conference. Key findings focused on the disease's ...
Among multiple sclerosis (MS) patients, those with a high relative abundance of Fusobacterium nucleatum together with other periodontal bacteria were more likely to have moderate to severe disability ...
Demyelinating diseases are any conditions that damage the protective coating on nerve cells, the myelin sheath. Some common demyelinating diseases of the central nervous system include multiple ...
—A study from a team at Cleveland Clinic sought to determine how living in a disadvantaged neighborhood may influence the timing of diagnosis and treatment for patients with neuromyelitis optica ...
The US Food and Drug Administration (FDA) has approved the humanized monoclonal antibody eculizumab (Soliris, Alexion Pharmaceuticals) for the treatment of neuromyelitis optica spectrum disorder ...
Immune cells must learn not to attack the body itself. A team of researchers from the Technical University of Munich (TUM) and the Ludwig Maximilian University of Munich (LMU) has discovered a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results